Background. Mannose-binding lectin (MBL) activates the complement system in an antibody-independent manner, enhances complement-mediated phagocytosis, and plays a major role in the regulation of inflammatory cytokine release by monocytes.
Mycobacterium tuberculosis (the main etiological agent of tuberculosis) infects more than one-third of the world's population [1] . This extraordinary success is due, at least in part, to the bacterium's ability to interfere with the host's immune system, an ability evolved by the pathogen in the course of a long-standing interaction with the host [2] . M. tuberculosis inhibits phagosome-lysosome fusion [3] , induces the production of anti-inflammatory cytokines [4] , and interferes with major histocompatibility complex class II expression on antigen-presenting cells [5] . The emergence of drug resistance and the widespread prevalence of HIV have further contributed to the worldwide escalation of the disease [6] . However, Ͻ0.1% of infected persons die of tuberculosis each year [7] . Environmental factors (HIV in the first place) [1] , pathogenic variation [1, 4, 8, 9] , and the genetic makeup of the host [9] determine whether an individual is going to die of tuberculosis. Twin studies [10] have provided primary evidence that host genes can influence resistance-or susceptibility-to M. tuberculosis. HLA-DRB1 [11] , VDR [12] , SLC11A1 (formerly NRAMP1) [13] , IFNG [14] , SP110 [15] , MAL [16] , and CCL2 (alias, MPC1) [17] are among the genes most consistently associated with tuberculosis.
The role played by the mannose-binding lectin gene MBL2 (for simplicity, referred to here as MBL) in predisposing humans to pulmonary tuberculosis is still controversial. According to some studies, low levels of MBL (associated with variant alleles at the promoter and exon 1 regions of MBL) protect against tuberculosis [18, 19] . Other investigators instead claim that protection against the disease is associated with high levels of MBL (controlled by the wild MBL alleles) [20, 21] . The present study was conducted to better define the association, if any, between this gene and pulmonary tuberculosis. MBL is a calcium-dependent (or C-type) lectin binding to several sugars (mannose and N-acetyl-D-glucosamine, in particular) expressed on a wide range of pathogens. On M. tuberculosis, the mannose is present in the form of lipoarabinomannan (LAM), a capsular lipoglycan. Virulent strains of M. tuberculosis use LAM as ligand for the macrophage mannose receptor during phagocytosis [22] . According to some authors, this pathway enhances the intracellular survival of M. tuberculosis by inhibiting phagosome-lysosome fusion in the host macrophages [23, 24] . In the circulation, MBL is associated with 4 proteins-MBL-associated serine protease (MASP) 1, 2, and 3 and Map 19 (a truncated version of MASP-2 [25] ). On binding to its ligands, MBL activates the complement system in an antibodyindependent manner via MASP-2, thus enhancing complementmediated phagocytosis [25] . MBL also plays a role in the regulation of inflammatory cytokines released by monocytes [25] and enhances Toll-like receptor (TLR) 2 and TLR6 signaling [26] . Human MBL is encoded by a single gene located on chromosome 10 in the region 10q21-24 [27] . The exon 1 of MBL contains 4 alleles (A, B, C, and D). Additional polymorphisms have been described at nt Ϫ550 (H and L), Ϫ221 (X and Y), and ϩ4 (P and Q) of the promoter [28] . Here, it is shown that resistance to tuberculosis is strongly influenced by MBL; in particular, the haplotype pair HYA/HYA confers resistance against pulmonary tuberculosis, whereas the haplotype pair LYB/LYD confers susceptibility to the same disease.
METHODS
Case patients and control subjects. The present study was approved by the ethics committee of Monaldi Hospital in Naples, Italy. The study included 277 case patients with pulmonary tuberculosis (192 male and 85 female; mean Ϯ SD age, 47 Ϯ 17 years) and 288 control subjects (175 male and 113 female; mean Ϯ SD age, 40 Ϯ 17 years). Patients provided informed consent. Diagnosis of pulmonary tuberculosis was based on findings of chest radiography and microscopic examination of sputum smears. The diagnosis was confirmed by polymerase chain reaction (PCR) and bacteriological tests. Control subjects were household contacts (persons genetically related or unrelated to the patients who, at the time of enrollment, had cohabited with the patients for at least 8 months). Control subjects did not present with any symptoms of pulmonary tuberculosis at chest radiography. Case patients and control subjects were all of Italian ethnicity, negative for HIV, and without medical conditions affecting immunity.
Sample size calculation. Preliminary data from 100 case patients and 100 control subjects showed that the frequencies of the MBL-O allele in the 2 groups were 0.51 and 0.28, respectively. On the basis of this information, it was calculated that a sample size of 274 case patients and 274 control subjects would provide 90% power to detect an odds ratio (OR) of 2 with a 2-sided ␣ value of .01. A total of 274 case patients and 288 control subjects were enrolled.
MBL genotyping. Promoter genotypes were determined by the presence or absence of a 373-bp band with appropriate combinations of primers complementary to the human MBL gene [29] . Reactions were performed in a 25-L volume containing ϳ75 ng of genomic DNA, 1.5 mmol/L MgCl 2 , 0.4 mol/L each primer, 0.2 mmol/L each deoxynucleotide triphosphate, and 1 U of GoTaq Flexi DNA Polymerase (Promega) in 5 L of ϫ5 reaction buffer (Promega). The thermal profile included 1 denaturation cycle (3 min at 95°C), 40 amplification cycles (30 s at 95°C, 30 s at 62°C, and 60 s at 72°C), and 1 elongation cycle (5 min at 72°C). Exon 1 genotypes were determined by the presence of a 128-bp (alleles A and D), 135-bp (alleles A and B), or 143-bp (alleles A and C) band with appropriate combinations of primers complementary to the human MBL gene [29] . Reactions were done as described above, except for the thermal profile, which included 1 denaturation cycle (2 min at 95°C), 35 amplification cycles (30 s at 95°C, 45 s at 58°C, and 45 s at 72 C), and 1 elongation cycle (5 min at 72 C). PCR products from 15 case patients and 15 control subjects were sequenced using 3730 DNA analyzer capillary arrays (Applied Biosystems). Sequencing confirmed PCR results in each participant.
MBL antibacterial activity. Individual wells of a 96-well plate were filled with M. tuberculosis (1 ϫ 10 5 cfu suspended in 100 L of PBS) and individual serum samples (100 L) from resistant or susceptible subjects. The plate was incubated for 12 days at 37°C. The content of each well was properly diluted (1 ϫ 10 Ϫ1 to 1 ϫ 10 Ϫ4 ) with PBS and plated on Middlebrook agar plates. Each sample was tested in triplicate. Controls (also set up in triplicate) included wells with individual serum samples (100 L) pretreated at 56°C for 30 min to inactivate MBL [30] . Specificity of MBL activity. Inhibition experiments were done on serum samples that were pretreated with specific MBL inhibitors (10 mmol/L EDTA, 20 mmol/L mannose, or 20 mmol/L N-acetyl-D-glucosamine) or rabbit anti-human MBL antiserum (Sigma; 2 L at 110 g/mL) or that were depleted of MBL by passage through a mannan-agarose column [30] . The inhibitor or antiserum was added to the individual serum samples (100 L) 30 min before the addition of M. tuberculosis.
Measurement of serum MBL concentration. Latex beads (10-m diameter; 4 ϫ 10 4 /tube; Sigma) were coated with rabbit anti-human MBL (100 L diluted 50-fold in PBS; Sigma), quenched with 2% milk powder (100 L; Sigma), and reacted, in succession, with individual serum samples (100 L diluted 20-fold in PBS containing 50 mmol/L CaCl 2 ), rabbit anti-human MBL (100 L diluted 50-fold), goat anti-rabbit MBL labeled with fluorescein (100 L diluted 200-fold; Sigma). In the standard curve, human serum was substituted for known quantities (100 L at 500 -20 ng/tube) of recombinant human MBL (Enzon Pharmaceuticals) diluted in human serum, which was depleted of MBL by passage through mannan-agarose. The lower limit of detection for the assay was 40 ng/mL. In specificity controls, the labeled reagent did not bind to beads when normal rabbit serum substituted for rabbit anti-human MBL or human serum was diluted in PBS containing 2 mmol/L EDTA to chelate Ca 2ϩ ions.
Test of case patients and control subjects for genetic homogeneity. To exclude stratification, all subjects included in the association study were typed by PCR for 10 singlenucleotide polymorphisms (SNPs) known to not be associated with tuberculosis [17] . Individual SNPs were all in HardyWeinberg equilibrium.
Statistical analysis. ORs and their 95% confidence intervals (CIs) were calculated and Fisher's exact test and Student's t test were conducted as described elsewhere [31] . HardyWeinberg equilibrium was calculated using the 2 test [32] . Relative risk reduction and attributable risk were calculated as described in Modiano et al. [33] and Miettinen [34] , respectively.
RESULTS

Effect of MBL exon 1 variants on M. tuberculosis infection. PCR analysisidentified4alleles(A,B,C,andD)inexon1ofMBL,2alleles(H and L)
at position Ϫ550 of the promoter, and 2 more (X and Y) at position Ϫ221. The primary analysis was performed to determine whether subjects with 2 copies of the wild allele (AA), 1 mutant allele (AB, AC, or AD; collectively referred to as AO), or 2 mutant alleles (BB, CC, DD, BC, BD, or CD; collectively referred to as OO) were present at different frequencies among case patients and control subjects. AA was more predominant among control subjects (166 control subjects vs. 55 casepatients),and OOwasmorepredominantamongcasepatients(61 case patients vs. 10 control subjects) (table 1). The A allele was significantly more frequent among control subjects than among case patients (0.77 vs. 0.49; P Ͻ 1 ϫ 10 Ϫ4 ). The same allele was clearly protective against pulmonary tuberculosis in the heterozygous state (OR, 0.23 [95% CI, 0.159 -0.346]; P Ͻ 1 ϫ 10 Ϫ8 ) and was more strongly protective in the homozygous state (OR, 0.05 [95% CI, 0.026 -0.113]; P Ͻ 1 ϫ 10 Ϫ8 ) (table 1). Case patients and control subjects were separately tested for Hardy-Weinberg equilibrium at the MBL locus and 10 additional polymorphic marker loci. Genotypic frequencies at the MBL locus were in equilibrium among control subjects but not among case patients, as expected for the association between MBL and tuberculosis (table 1). Genotypic frequencies at the marker loci were instead in equilibrium among both case patients and control subjects (data not shown), excluding the presence of stratification within the population being studied [35] .
Effects of MBL haplotypes on M. tuberculosis infection. The Ϫ550 (H and L) and Ϫ221 (X and Y) promoter alleles are inherited along with the structural alleles in the form of haplotypes [28] classified as having 2 copies of the HYA haplotype (HYA/HYA), 1 copy (HYA/Ϫ), or none (Ϫ/Ϫ), the HYA/HYA haplotype pair was more frequent among control subjects (30 control subjects vs. 2 case patients), and the Ϫ/Ϫ haplotype pair was more frequent among case patients (199 case patients vs. 123 control subjects). The frequency of the HYA haplotype was 0.34 among control subjects and 0.14 among case patients (P Ͻ 1 ϫ 10 Ϫ4 ). The HYA haplotype was clearly protective against pulmonary tuberculosis when present in double copy (OR, 0.04 [95% CI, 0.01-0.175]; P Ͻ 1 ϫ 10 Ϫ8 ) or single copy (OR, 0.12 [95% CI, 0.028 -0.531]; P Ͻ 1 ϫ 10 Ϫ3 ) (table 3). The reductions in the relative risk [33] of pulmonary tuberculosis associated with the HYA/Ϫ and HYA/HYA haplotype pairs were 88% and 95%, respectively. Given the frequencies of the 2 haplotype pairs among control subjects (table 2) Several haplotype pairs were characteristic of case patients (table 2). The most frequent among them, LYB/LYD, was tested for association with pulmonary tuberculosis (table 4). The results (OR, 49 [95% CI, 2.9 -812]; P Ͻ 1 ϫ 10 Ϫ6 ) provided clear evidence that this haplotype pair increases the disease risk. By Miettinen's formula [34] , it was calculated that 7% of the cases of pulmonary tuberculosis detected in this study were associated with possession of LYB/LYD.
The promoter and exon 1 alleles of the human MBL gene differ from each other in 1 single base substitution [36] . Therefore, quite remarkably, the ability of a haplotype to promote protection or susceptibility can depend on a single nucleotide change, as in the case of the haplotype pairs HYA/HYA versus HYA/HYD, HYA/HYA versus LYA/LYA, or HYA/HYA versus HXA/HXA.
Biological plausibility of the association. One function of the MBL protein is pathogen opsonization and phagocytosis [37] . To probe a possible difference in the biological activity of the protein between resistant and susceptible subjects, M. tuberculosis (1 ϫ 10 5 cfu/mL) was incubated in vitro in the presence of heat-inactivated and noninactivated serum (100 L; 50% diluted) from 6 HYA/HYA control subjects, 6 LYB/LYC and 6 LYB/ LYD case patients, and the 2 HYA/HYA case patients identified during the course of this study (table 2). In describing this experiment, we will refer to the 6 HYA/HYA control subjects and the 2 HYA/HYA case patients as HYA/HYA-r (for resistant) and HYA/HYA-s (for susceptible), respectively. Each serum sample was tested in triplicate. The serum samples from HYA/HYA-r participants displayed significantly higher antibacterial activity than did those from the LYB/LYC, LYB/LYD, or HYA/HYA-s participants (figure 1). The evidence that heat inactivation destroys the antibacterial activity of the serum suggests that this activity is indeed mediated by MBL, a heat-labile lectin [30] . Involvement of MBL in the antibacterial activity was also indicated by the following observations. The antibacterial activity was inhibited by preincubation of the serum with 10 mmol/L EDTA, 20 mmol/L mannose, or 20 mmol/L N-acetyl-Dglucosamine (figure 1), known to specifically inhibit MBL [30] . Most importantly, the antibacterial activity was inhibited in the presence of rabbit anti-human MBL or after passage of the serum through a mannan-agarose column (figure 1).
The antibacterial test was then extended to participants with the more frequent haplotype pairs-HYA/LYB (40 control subjects and 35 case patients), HYA/LYA (64 control subjects and 16 case patients), LYA/LYB (35 control subjects and 53 case patients)-and 24 more HYA/HYA control subjects. Again, each serum sample was tested in triplicate. The HYA/HYA participants all displayed significantly higher antibacterial activity (figure 2) . A significant difference between case patients and control subjects was observed for the haplotype pairs HYA/LYB and HYA/LYA but not for the haplotype pair LYA/LYB (figure 2). This result is consistent with the gene dose effect detected epidemiologically (table 3) . The measurement of serum MBL displayed a similar trend. The HYA/HYA control subjects showed a significantly higher median MBL level than did the 2 HYA/HYA case patients and the participants (case patients or control subjects) with a non-HYA/HYA haplotype pair (figure 3). With 2 exceptions, genetic and functional (antibacterial activity and MBL protein level) analyses yielded concordant results (figures 1 and 3), lending biological significance to the protective role played by the HYA/HYA haplotype pair against M. tuberculosis infection and the predisposing role played by the LYB/LYD haplotype pair. At the same time, these results call for an explanation of the resistance displayed by the control subjects without the HYA haplotype (1 or 2 copies) (table 2). It has been speculated that these subjects might have 1 or more of the numerous genes that, in addition to MBL, confer resistance to tuberculosis [1] .
Hypothyroidism [38] is known to cause low MBL levels. The 2 HYA/HYA patients displayed normal levels of triiodothyronine, thyroxine, and thyrotropin (data not shown). Why the 2 HYA/HYA patients expressed a low level of serum MBL therefore remains unexplained. With this caveat, this phenomenon serves as a reminder that background factors (genetic and environmental) often modify the expression of genes [39] . Detection of these factors requires extremely large samples and specific experimental designs [40] .
DISCUSSION
The present study provides evidence that, depending on the haplotype pair of the host, MBL can protect the host against tuberculosis or predispose the host to the disease. Thus, depending on the context, MBL behaves as Dr. Jekyll or Mr. Hyde [41] . The data supporting a protective role for MBL are as follows. First, the HYA/HYA subjects, with 2 exceptions, were found among the control subjects (OR, 0.09; P Ͻ 1 ϫ 10 Ϫ8 ). This P value, well below the threshold (5 ϫ 10 Ϫ5 ) proposed for the declaration of statistical evidence of association [42] , places the study directly in the first class of the BADGE (Better Associations for Diseases and Genes) system [43] . First-class associations are expected to be reproducible even in the absence of other evidence supporting the association [43] . Given the current level of concern over the unreliable nature of case-control studies [44] , our results are reassuring. Second, HYA/HYA control subjects, who had been exposed to con- 1 and 3 ). This functional link between the HYA/HYA haplotype pair and tuberculosis provides strong prior probability to the association [42, 44] . Thus, to the strength of evidence for association from epidemiological data (P value), one can add the biological plausibility of the gene product. Fourth, the effect of MBL on the disease is clearly apparent when analyzed at the allele level (table 1) as well  as the haplotype level (table 3) . At both levels, 2 copies of the A allele or HYA haplotype protect better than just 1 copy (table 1  and 3 ). The correlation between the MBL locus and resistance to tuberculosis must necessarily be robust to stand up to this stringent analysis. We also found an MBL haplotype combination that, in stark contrast to that discussed above, confers susceptibility to tuberculosis. Several haplotype pairs were present only among case patients. With 1 exception, they were too rare to permit appropriate estimation of their association with tuberculosis (table 2) . However, LYB/LYD, the most frequent haplotype pair, was found to increase the risk of tuberculosis significantly (OR, 49; P Ͻ 1 ϫ 10 Ϫ6 ) (table 4). Given its frequency in the population, LYB/LYD increased the disease risk by 7%.
These results raise the question as to why haplotype combinations conferring susceptibility to tuberculosis are not removed from the population by natural selection. We do not have definite answers, but we can propose some plausible explanations. The role played MBL is not limited to protection from tuberculosis. MBL recognizes many pathogens [25] and triggers signaling pathways of the adaptive immune response to pathogens, culminating in the activation of proinflammatory genes [37] . However, inflammation, if excessive, can become dangerous to the host. One can speculate that the numerous polymorphic sites (in the promoter and the coding region of MBL) and the hormonal influence on MBL synthesis [38] mightservetokeepthisgeneundertightcontrol.Thus,somehaplotype combinations might be conserved in the population to protect against pathogens and others to protect against excessive inflammation. Moreover, the haplotype pair conferring susceptibility to a pathogen might be protective against another pathogen. A precedent is set by the genes predisposing to gastric ulcer, which also confer resistance to human tuberculosis [45] . Although pathogens are important, other forces might also help in maintaining multiple haplotypes at the MBL locus. For example, the haplotype conferring susceptibility to tuberculosis might not be selected against because it is involved in an essential developmental or physiological process. Again, a precedent exists: the Drosophila melanogaster innate immunity gene cactus (the fly counterpart of the NF-B-inhibitor IkB), which plays an important role during larval hematopoiesis [46] .
Protection against tuberculosis, according to some studies, is associated with a low level of MBL [18, 19] ; according to this study and others [20, 21] , however, it is instead associated with a high level of MBL. An explanation for these divergent results is not simple and is most likely to emerge from a multicenter study rather than a single-center one. At present, we favor the explanation that the discrepancy in results reflects differences in the abilities of M. tuberculosis strains to bind to MBL. Several pieces of evidence support this concept. There is growing evidence that M. tuberculosis strains are genetically heterogeneous (much more so than previously thought) and are associated with specific geographical regions [2, 4] . Over the course of time, host and M. tuberculosis coevolved, and individual strains are now adapted to their own populations [47] . The interaction between host genotype and M. tuberculosis genotype sometimes becomes very intimate; for example, patients with the C allele of TLR2 are more likely to have tuberculosis caused by the Beijing strain [47] . Finally-and more directly relevant to the question we hope to consider in the future-a large heterogeneity in MBL binding has already been displayed among several organisms and within the same organism [21] . There is, in fact, evidence that even modest sugar alterations on the surface of the bacterium can inhibit MBL binding [21] .
In conclusion, our findings show that the MBL haplotype pair HYA/HYA confers resistance to tuberculosis, whereas the haplotype pair LYB/LYD confers susceptibility to the disease. This study highlights the difficulty in comparing results from studies conducted in different populations, even when the same allele or haplotype is studied and the same study design is used. 
